(S)-METHYL 3-(4-BROMOPHENYL)-2-((TERT-BUTOXYCARBONYL)AMINO)PROPANOATE, 95.0%, 1g

5-methyl-1H-pyrazole-4-carbaldehyde, 95.0%, 1g

(R)-(-)-2,2,2-Trifluoro-1-(9-anthryl)ethanol [e.e. Determination Reagent by NMR]>99.0%(GC)100mg

4-(Trifluoromethyl)-dl-phenylalanine, 97.0%, 1g

Cyclopentylsulfonyl chloride, 95.0%, 100mg

Methyl 6-bromo-1H-benzoimidazole-2-carboxylate, 95.0%, 5g

N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarboxamide, 98%, 1g

5,6-Diphenylpyrazin-2-ol, 95.0%, 25g

Pipettes Pasteur graduées 3 ml, Non stériles, 1 x 500, 500 pièces

Methacrylamide, 98.0%, 25g

(2R,5S)-5-Hydroxypiperidine-2-carboxylic acid hydrochloride, 97%, 100mg

2-Amino-6-fluorobenzoic acid, 97.0%, 10g

(2R)-2-(3-BROMOPHENYL)PYRROLIDINE, 95.0%, 1g